Nevertheless, one clinical study that focused on peripheral blood mononuclear cells reported that initial elevations of PARKIN/PINK1 and NIX mitophagy markers in prediabetes patients eventually decreased across newly diagnosed and advanced duration T2D patients [114]. The gene discussed is PRKN; the disease is prediabetes syndrome.